clinical_trials
STAT+: Roivant says closely watched immune drug succeeded in new eye disease
Confidence88·multiple reportsImportance90NP-EVT-20261021-59BD139
An immune drug from Roivant could be headed to a new market, after the company reported positive trials in the eye disease non-infectious uveitis.
Read the original at the primary source
STAT+: Roivant says closely watched immune drug succeeded in new eye disease
Jason Mast · 10/21/2026, 12:05:54 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —